Theradiag Acquires miRNA Firm Prestizia
June 27, 2012
Theradiag Acquires miRNA Firm Prestizia
Full-text access for registered users only.
Existing users login here.
New to GenomeWeb? Register here quickly for free access.
New to GenomeWeb? Register here quickly for free access.
Related Stories
- France's Theradiag Buys microRNA Diagnostics Shop Prestizia
June 28, 2012 / Gene Silencing News - Theradiag Expanding microRNA Assay Plans with HIV, Anti-Obesity CDx Agreement
May 2, 2013 / Gene Silencing News - Theradiag Receives $1.6M to Develop Test Kits for HIV/AIDS, Obesity Project
April 9, 2013 / GenomeWeb Daily News - Rosetta Releases miRview Kidney Test Validation Study, Anticipates Medicare Coverage Decision
April 4, 2013 / Gene Silencing News - Lab21, IntegraGen Co-developing CDx for Colorectal Cancer Therapy
February 22, 2013 / GenomeWeb Daily News